Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Goodwill & Intangibles of $1.7 million in Q1 2026, down 3.08% on a QoQ basis from $1.8 million in Q4 2025, and down 11.37% year-over-year from $2.0 million in Q1 2025.
Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Goodwill & Intangibles across 11 years of filings, most recently posting $1.7 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 11.37% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 11.37% YoY) and the FY2025 annual result came in at $1.8 million, down 11.11% from the prior year.
- Goodwill & Intangibles retreated to $1.7 million in Q1 2026, from $1.8 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $2.6 million in Q1 2022 and troughed at $1.7 million in Q1 2026.
- A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Goodwill & Intangibles.
- Biggest YoY gain for Goodwill & Intangibles was 7.84% in 2022; the steepest drop was 38.23% in 2022.
- Tracing ACHV's Goodwill & Intangibles over 5 years: stood at $2.5 million in 2022, then slipped by 9.01% to $2.2 million in 2023, then dropped by 10.0% to $2.0 million in 2024, then slipped by 11.11% to $1.8 million in 2025, then retreated by 3.08% to $1.7 million in 2026.
- Business Quant data shows ACHV's Goodwill & Intangibles at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 2.29 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 2.40 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.56 Mn |
| Mar 31, 2022 | 2.62 Mn |
| Dec 31, 2021 | 2.68 Mn |
| Sep 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 4.15 Mn |